查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1818188

FeNO 测试市场报告：2031 年趋势、预测与竞争分析

FeNO Testing Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球 FeNO 检测市场前景光明，医院和诊所市场蕴藏着巨大机会。预计 2025 年至 2031 年期间，全球 FeNO 检测市场的复合年增长率将达到 14.1%。该市场的主要驱动因素包括呼吸系统疾病盛行率的上升、人们对早期诊断和个人化医疗的认识不断提高，以及空气污染水平的上升。

  • Lucintel 预测，由于气喘和慢性呼吸系统疾病的盛行率不断上升，按类型划分，一氧化氮独立监测仪预计在预测期内将出现高速增长。
  • 根据应用，由于先进的医疗基础设施和对呼吸护理计划的高度认识，医院预计将实现高成长。
  • 按地区划分，预计北美在预测期内将经历最高的成长。

FeNO测试市场的新趋势

由于技术进步、医疗保健政策以及对非侵入性诊断方法日益增长的需求，FeNO 检测市场正在快速发展。这些新兴趋势反映了医疗保健领域的广泛变化，包括对个人化医疗和更有效的慢性病管理的追求。以下是塑造 FeNO 检测市场未来的五大关键趋势。

  • 家用设备日益普及：可携式、易于使用的 FeNO 检测设备正在开发中，使患者能够在家中监测自身病情。这一趋势正在改变气喘管理，为患者提供即时数据，并支持制定更个人化的治疗方案。家用设备使患者能够在就诊之外随时掌握病情，从而提高治疗依从性并减少就诊次数。随着医疗保健模式转向更加以患者为中心的模式，这些设备在帮助患者更有效地管理呼吸健康方面发挥关键作用。
  • 与数位健康平台整合：FeNO 检测设备正日益与数位健康平台集成，从而实现数据无缝传输至医疗服务提供者。这一趋势有助于更好地监测气喘和其他呼吸系统疾病，即时数据则有助于医生做出更明智的决策。 FeNO 检测与电子健康记录(EHR) 和远端医疗平台的整合也透过增强患者与医疗专业人员之间的沟通，改善了患者照护，从而能够及时调整治疗方案并改善疗效。
  • 设备小型化和便携性的进步：市场持续见证着 FeNO 检测设备的创新，使其变得更小、更便携、更易于使用。小型化使医疗保健提供者能够在更多环境中使用这些设备，例如行动诊所和偏远地区。这一趋势使得 FeNO 检测在医疗基础设施有限的地区更容易获得，因为在这些地区，携带式、小型设备更易于运输和部署。携带式FeNO 检测在农村地区和开发中国家尤其有益。
  • 非侵入性诊断工具需求日益增长：FeNO 检测是医疗保健领域非侵入性诊断趋势的一部分。随着患者偏好微创方法，FeNO 检测因其无需抽血或其他侵入性操作即可测量气道发炎而日益普及。这一趋势对于管理气喘等需要频繁监测的慢性疾病尤其重要。非侵入性检测方法可提高患者的舒适度，并有望成为慢性病管理通讯协定的标准组成部分。
  • 扩大报销范围：随着 FeNO 检测的临床益处日益得到认可，包括美国和欧洲国家在内的许多国家正在扩大 FeNO 检测的报销范围。将 FeNO 检测纳入保险范围可以降低成本门槛，使更多人群更容易获得此检测。在许多地区，FeNO 检测已被纳入气喘管理的临床指南，确保医疗保健提供者将 FeNO 检测作为全面治疗计划的一部分。这一趋势正在推动 FeNO 检测的广泛应用。

家用设备、数位整合、设备小型化、非侵入性诊断需求以及报销政策的不断扩大等新兴趋势正在显着重塑FeNO检测市场。这些趋势将透过改善FeNO检测的可及性并加强其与常规医疗保健实践的整合来推动成长，最终改善全球呼吸系统疾病的管理。

FeNO 测试市场的最新趋势

随着技术的进步和广泛应用，FeNO 检测市场也出现了一系列近期趋势。这些发展反映了产品设计的创新、人们对呼吸系统疾病的认识不断提高以及医疗基础设施的进步。以下是近期影响各地区 FeNO 检测市场的一些关键趋势：

  • 手持式 FeNO 测试仪的推出：FeNO 测试市场最重要的发展之一是手持式和可携式FeNO 测试设备的推出。这些设备支援就地检验，使医疗保健提供者能够更轻鬆地快速评估患者的气道发炎。手持式测试仪越来越多地用于急诊室、诊所甚至家庭的气喘监测。这一发展提高了 FeNO 测试的便利性和可近性，尤其是在资源有限的环境中。
  • 远端医疗与 FeNO 检测整合：随着远端医疗的兴起，FeNO 检测设备正被整合到远端医疗平台。这种整合使患者能够在家中进行 FeNO 测量，并与医疗保健提供者远端共用数据。这一趋势对慢性呼吸系统疾病患者尤其有利，因为它可以持续监测并及时调整治疗方案。它还能改善专科医疗的可近性，尤其是在农村和服务不足的地区。
  • 提升设备灵敏度和准确度：近期进展主要集中在提高 FeNO 检测设备的灵敏度和准确度。较新的型号能够检测较低浓度的一氧化氮，从而获得更准确的读数，并能够更早诊断气道发炎。这些改进对于确保 FeNO 检测继续作为气喘和 COPD 管理的可靠工具至关重要，有助于做出更准确、更有效的治疗决策。
  • 扩大 FeNO 检测在临床指引中的应用：FeNO 检测正日益被纳入全球气喘管理的临床指引。许多国家的医疗保健系统已经认识到 FeNO 检测在气喘诊断和管理中的重要性，并因此而广泛采用这项技术。这项进展提高了医疗保健专业人员对 FeNO 检测的接受度，并促进了其在常规临床实践中的应用。
  • 推出价格实惠的 FeNO检测套组：为了提高可及性，一些製造商正在针对低收入群体和开发中国家推出价格实惠的 FeNO检测套组。这些经济高效的套件为那些无法负担昂贵设备的地区大规模部署提供了可行的选择。价格实惠的 FeNO 检测方案的普及预计将推动新兴市场的成长，这些市场中呼吸系统疾病盛行，但医疗基础设施可能有限。

FeNO 检测的最新趋势，包括手持设备、与远端医疗、准确性的提高、纳入临床指南以及价格实惠的套件，正在提高 FeNO 检测的可及性、准确性和可整合性。这些技术创新正在促进市场的成长和扩张，使 FeNO 检测成为气喘和呼吸系统疾病管理的重要工具。

目录

第一章执行摘要

第二章 市场概况

  • 背景和分类
  • 供应链

第三章：市场趋势及预测分析

  • 宏观经济趋势与预测
  • 产业驱动力与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

4. 全球 FeNO 测试市场（按类型）

  • 概述
  • 按类型进行吸引力分析
  • 一氧化氮独立监测仪：趋势与预测（2019-2031）
  • 一氧化氮手持式监测仪：趋势与预测（2019-2031）
  • 其他：趋势与预测（2019-2031）

5. 全球 FeNO 测试市场（按应用）

  • 概述
  • 按用途进行吸引力分析
  • 医院：趋势与预测（2019-2031）
  • 诊所：趋势与预测（2019-2031）
  • 其他：趋势与预测（2019-2031）

第六章 区域分析

  • 概述
  • 区域 FeNO 测试市场

7. 北美FeNO检测市场

  • 概述
  • 美国FeNO测试市场
  • 墨西哥的FeNO检测市场
  • 加拿大 FeNO 测试市场

8. 欧洲FeNO检测市场

  • 概述
  • 德国FeNO测试市场
  • 法国FeNO检测市场
  • 西班牙的FeNO测试市场
  • 义大利 FeNO 测试市场
  • 英国FeNO 测试市场

9. 亚太地区 FeNO 检测市场

  • 概述
  • 日本的FeNO检测市场
  • 印度FeNO测试市场
  • 中国FeNO检测市场
  • 韩国FeNO检测市场
  • 印尼FeNO测试市场

10. 世界其他地区 FeNO 检测市场

  • 概述
  • 中东FeNO检测市场
  • 南美洲 FeNO 检测市场
  • 非洲 FeNO 检测市场

第11章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
    • 竞争对手之间的竞争
    • 买方的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁
  • 市占率分析

第十二章：机会与策略分析

  • 价值链分析
  • 成长机会分析
    • 按类型分類的成长机会
    • 按应用分類的成长机会
  • 全球 FeNO 测试市场的新趋势
  • 战略分析
    • 新产品开发
    • 认证和许可
    • 合併、收购、协议、合作和合资企业

第十三章 价值链主要企业的公司简介

  • 竞争分析
  • Guangzhou Kingmed Diagnostics
  • Hangzhou Clongene BIoTech
  • Shanghai Fosun Long March Medical Science
  • Nanjing Norman Biological Technology
  • Beijing Eastwest Harmony Medical Devices
  • Guangzhou Yercon Diagnostic
  • Aeonmed

第十四章 附录

  • 图表目录
  • 表格一览
  • 调查方法
  • 免责声明
  • 版权
  • 简称和技术单位
  • 关于我们
  • 联络处

The future of the global FeNO testing market looks promising with opportunities in the hospital and clinic markets. The global FeNO testing market is expected to grow with a CAGR of 14.1% from 2025 to 2031. The major drivers for this market are the rising prevalence of respiratory diseases, growing awareness of early diagnosis & personalized medicine, and the rising air pollution levels.

  • Lucintel forecasts that, within the type category, nitric oxide standalone monitor is expected to witness higher growth over the forecast period due to increasing prevalence of asthma and chronic respiratory diseases.
  • Within the application category, hospital is expected to witness the higher growth due to advanced healthcare infrastructure and high awareness for respiratory care programs.
  • In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the FeNO Testing Market

The FeNO testing market is evolving rapidly, driven by advancements in technology, healthcare policies, and growing demand for non-invasive diagnostic methods. These emerging trends reflect broader changes in healthcare, including personalized medicine and the push for more effective chronic disease management. Below are five key trends shaping the future of the FeNO testing market.

  • Increasing Adoption of Home-Use Devices: Portable, user-friendly FeNO testing devices are being developed to allow patients to monitor their condition at home. This trend is transforming asthma management by providing patients with real-time data, enabling more personalized treatment plans. Home-use devices allow patients to track their condition outside of medical appointments, improving adherence to treatment and reducing hospital visits. As healthcare shifts towards more patient-centric models, these devices play a crucial role in empowering individuals to manage their respiratory health more effectively.
  • Integration with Digital Health Platforms: FeNO testing devices are increasingly being integrated with digital health platforms, enabling seamless data transfer to healthcare providers. This trend allows for better monitoring of asthma and other respiratory conditions, with real-time data helping doctors make more informed decisions. The integration of FeNO testing with electronic health records (EHRs) and telemedicine platforms is also improving patient care by enhancing communication between patients and healthcare professionals, ensuring timely adjustments to treatment plans and improving outcomes.
  • Advancements in Device Miniaturization and Portability: The market is seeing continuous innovation in making FeNO testing devices smaller, more portable, and easier to use. Miniaturization makes it possible for healthcare providers to use these devices in more settings, such as mobile clinics or remote areas. This trend is making FeNO testing more accessible in regions with limited healthcare infrastructure, where mobile or compact devices are easier to transport and deploy. Portable FeNO testing is particularly beneficial in rural areas and developing countries.
  • Growing Demand for Non-Invasive Diagnostic Tools: FeNO testing is part of a broader trend towards non-invasive diagnostics in healthcare. As patient preferences shift towards less invasive methods, FeNO testing is gaining popularity because it can measure airway inflammation without requiring blood draws or other invasive procedures. This trend is particularly relevant in the management of chronic diseases like asthma, where frequent monitoring is necessary. Non-invasive testing methods improve patient comfort and are expected to become a standard part of chronic disease management protocols.
  • Expansion of Reimbursement Policies: Reimbursement policies for FeNO testing are expanding in many countries, including the U.S. and European nations, as the clinical benefits of the test become more recognized. The inclusion of FeNO testing in insurance coverage helps reduce the cost barrier, making it more accessible to a broader population. In many regions, FeNO testing is being integrated into clinical guidelines for asthma management, ensuring that healthcare providers use it as part of a comprehensive treatment plan. This trend is contributing to the widespread adoption of FeNO testing.

Emerging trends such as home-use devices, digital integration, device miniaturization, demand for non-invasive diagnostics, and expanded reimbursement policies are significantly reshaping the FeNO testing market. These trends are driving growth by improving access to FeNO testing and enhancing its integration into routine healthcare practices, which will ultimately improve the management of respiratory diseases globally.

Recent Developments in the FeNO Testing Market

The FeNO testing market has seen numerous developments in recent years as the technology becomes more advanced and widely adopted. These developments reflect innovations in product design, increasing awareness of respiratory conditions, and advancements in healthcare infrastructure. The following are key recent developments that are shaping the FeNO testing market across various regions.

  • Introduction of Handheld FeNO Testers: One of the most significant developments in the FeNO testing market is the launch of handheld and portable FeNO testing devices. These devices allow for point-of-care testing, making it easier for healthcare providers to assess patients' airway inflammation quickly. Handheld testers are increasingly used in emergency rooms, clinics, and even at home for monitoring asthma. This development enhances the convenience and accessibility of FeNO testing, particularly in resource-limited settings.
  • Integration of FeNO Testing with Telemedicine: With the rise of telemedicine, FeNO testing devices are being integrated into telehealth platforms. This integration allows patients to take FeNO measurements at home and share the data with healthcare providers remotely. This trend is particularly beneficial for patients with chronic respiratory conditions, as it allows for continuous monitoring and timely adjustments to treatment plans. It also improves access to specialized care, particularly in rural or underserved areas.
  • Improvements in Device Sensitivity and Accuracy: Recent advancements have focused on improving the sensitivity and accuracy of FeNO testing devices. New models are able to detect lower concentrations of nitric oxide, providing more accurate readings and enabling earlier diagnosis of airway inflammation. These improvements are critical in ensuring that FeNO testing is a reliable tool for asthma and COPD management, leading to more precise and effective treatment decisions.
  • Expansion of FeNO Testing in Clinical Guidelines: FeNO testing is becoming increasingly integrated into clinical guidelines for asthma management worldwide. In many countries, national healthcare systems have recognized the importance of FeNO measurements in diagnosing and managing asthma, leading to more widespread use of the technology. This development is increasing the acceptance of FeNO testing among healthcare professionals and encouraging its adoption in routine clinical practice.
  • Launch of Affordable FeNO Testing Kits: To increase accessibility, some manufacturers have launched affordable FeNO testing kits aimed at low-income populations or developing countries. These cost-effective kits provide a viable option for large-scale deployment in areas where expensive equipment might be unaffordable. The availability of affordable FeNO testing options is expected to drive market growth in emerging markets, where respiratory conditions are prevalent but healthcare infrastructure may be limited.

Recent developments in FeNO testing, such as handheld devices, telemedicine integration, improved accuracy, clinical guideline inclusion, and affordable kits, are enhancing the accessibility, accuracy, and integration of FeNO testing. These innovations are contributing to the growth and expansion of the market, making FeNO testing an essential tool in the management of asthma and respiratory diseases.

Strategic Growth Opportunities in the FeNO Testing Market

As the FeNO testing market continues to expand, numerous growth opportunities exist across various applications. These opportunities are driven by the increasing prevalence of asthma and other respiratory conditions, technological advancements, and the growing demand for personalized healthcare. Below are five key strategic growth opportunities by application that can propel the FeNO testing market forward.

  • Growth in Point-of-Care Testing: Point-of-care testing is a significant growth opportunity for the FeNO testing market. The increasing demand for faster diagnostics in emergency rooms, clinics, and even in home settings is driving the adoption of portable FeNO testing devices. Point-of-care testing enables immediate assessment of airway inflammation, improving decision-making for asthma management and treatment. As healthcare systems move toward more accessible, patient-centered care, the demand for point-of-care FeNO testing solutions will continue to grow.
  • Expansion in Telemedicine Applications: Telemedicine offers a key growth opportunity for the FeNO testing market, particularly as more healthcare providers embrace remote patient monitoring. FeNO testing devices integrated into telehealth platforms allow for continuous asthma management, offering patients the convenience of monitoring their condition at home. This trend is especially valuable in rural areas or regions with limited access to healthcare specialists, making FeNO testing more accessible and effective in managing chronic respiratory conditions.
  • Increasing Use in Clinical Research: FeNO testing is increasingly being used in clinical research to study the effects of different asthma treatments and interventions. Researchers are adopting FeNO measurements to monitor inflammation and treatment response, making it a valuable tool for drug development and clinical trials. This growing use of FeNO testing in research provides opportunities for manufacturers to expand their market presence and target the pharmaceutical and clinical research sectors.
  • Focus on Emerging Markets: Emerging markets, particularly in regions such as Asia-Pacific and Latin America, present significant growth opportunities for the FeNO testing market. The rising prevalence of asthma and other respiratory diseases in these regions, coupled with improvements in healthcare infrastructure, is increasing demand for advanced diagnostic tools like FeNO testing. Expanding into these markets with cost-effective and portable solutions can drive market growth and improve access to high-quality asthma management in underserved regions.
  • Development of Personalized Medicine Applications: As personalized medicine becomes more prevalent, there is an increasing opportunity for FeNO testing to play a pivotal role in individualized treatment plans for asthma and COPD patients. By measuring airway inflammation in real-time, FeNO testing provides critical information that helps tailor treatments based on the patient's specific needs. The integration of FeNO testing into personalized medicine frameworks will drive its adoption and further establish its importance in chronic disease management.

Strategic growth opportunities in point-of-care testing, telemedicine, clinical research, emerging markets, and personalized medicine are driving the FeNO testing market forward. These opportunities are broadening the scope of FeNO testing and making it more accessible, efficient, and effective in managing asthma and respiratory diseases.

FeNO Testing Market Driver and Challenges

The FeNO testing market is influenced by a range of drivers and challenges, including technological advances, regulatory changes, and economic factors. These elements shape the growth trajectory and adoption of FeNO testing across different regions and applications. Below are five key drivers and three main challenges impacting the market, providing a comprehensive overview of the factors at play.

The factors responsible for driving the FeNO testing market include:

1. Increasing Prevalence of Respiratory Diseases: The rising global incidence of asthma and COPD is a major driver for the FeNO testing market. As the number of patients with these conditions increases, the demand for effective and non-invasive diagnostic tools like FeNO testing grows. FeNO testing helps in early detection and personalized treatment, making it an essential tool in managing respiratory diseases.

2. Technological Advancements in FeNO Testing Devices: Recent innovations in FeNO testing devices, including portable, handheld models and improved sensitivity, are driving market growth. These advancements make FeNO testing more accessible and accurate, allowing for wider adoption in both clinical and home settings. The continuous improvement of FeNO testing technology is enhancing the device's usability and increasing its clinical relevance.

3. Government Initiatives and Support for Respiratory Health: Governments around the world are investing in better healthcare infrastructure and promoting disease prevention programs, especially for chronic diseases like asthma. These initiatives support the adoption of FeNO testing as a valuable tool for early diagnosis and management. Policies that expand reimbursement for FeNO testing also boost market growth by making the technology more affordable and accessible.

4. Rising Demand for Personalized Healthcare: The shift towards personalized medicine, where treatments are tailored to individual patient needs, is driving demand for tools like FeNO testing. By measuring inflammation in the airways, FeNO testing helps healthcare providers personalize asthma management plans, ensuring better treatment outcomes. This growing trend toward individualized care is a strong driver for the market.

5. Expanding Healthcare Access in Emerging Markets: As healthcare access improves in emerging markets, the demand for advanced diagnostic tools like FeNO testing increases. The availability of portable and cost-effective FeNO testing devices is facilitating market growth in regions like Asia-Pacific, where the prevalence of asthma is on the rise. Expanding access to FeNO testing in these regions is a key driver for the market.

Challenges in the FeNO testing market are:

1. High Costs of FeNO Testing Devices: Despite the benefits of FeNO testing, the high cost of devices and related testing can be a barrier to adoption, particularly in low-income regions. While prices are decreasing with technological advancements, affordability remains a challenge for broader market penetration.

2. Regulatory Hurdles and Approval Delays: The approval process for medical devices, including FeNO testing equipment, can be lengthy and complex, with varying regulatory standards across regions. These hurdles may slow the introduction of new devices to the market and impact the speed of innovation, limiting the potential for rapid market growth.

3. Lack of Awareness and Training: In some regions, healthcare providers may lack awareness of FeNO testing or may not be trained in its use. This can lead to underutilization of the technology, particularly in emerging markets. Education and training programs are needed to ensure that healthcare providers can effectively integrate FeNO testing into their practice.

The FeNO testing market is being shaped by drivers such as the increasing prevalence of respiratory diseases, technological advancements, government support, demand for personalized healthcare, and expanded access in emerging markets. However, challenges like high device costs, regulatory delays, and a lack of awareness must be addressed to unlock the full potential of the market.

List of FeNO Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies FeNO testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the FeNO testing companies profiled in this report include-

  • Guangzhou Kingmed Diagnostics
  • Hangzhou Clongene Biotech
  • Shanghai Fosun Long March Medical Science
  • Nanjing Norman Biological Technology
  • Beijing Eastwest Harmony Medical Devices
  • Guangzhou Yercon Diagnostic
  • Aeonmed

FeNO Testing Market by Segment

The study includes a forecast for the global FeNO testing market by type, application, and region.

FeNO Testing Market by Type [Value from 2019 to 2031]:

  • Nitric Oxide Standalone Monitor
  • Nitric Oxide Handheld Monitor
  • Others

FeNO Testing Market by Application [Value from 2019 to 2031]:

  • Hospital
  • Clinic
  • Others

FeNO Testing Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the FeNO Testing Market

The FeNO (Fractional exhaled Nitric Oxide) testing market has experienced significant growth due to its role in the diagnosis and management of respiratory conditions like asthma. This non-invasive method helps measure airway inflammation, offering a critical tool for clinicians in assessing asthma severity and treatment effectiveness. As healthcare systems evolve and patient care becomes more personalized, the adoption of FeNO testing is increasing globally. Below, we highlight recent developments in FeNO testing across key markets such as the United States, China, Germany, India, and Japan, showcasing innovations, regulatory changes, and growing adoption.

  • United States: In the U.S., FeNO testing is gaining popularity as a standard tool for managing asthma and chronic obstructive pulmonary disease (COPD). The increased focus on precision medicine and personalized healthcare has fueled the demand for more accurate and non-invasive diagnostic tools. Recent advancements in FeNO testing devices, such as portable and handheld devices, have improved accessibility and patient compliance. Additionally, healthcare providers are increasingly incorporating FeNO measurements alongside traditional tests for better asthma control. Medicare and private insurers have expanded reimbursement policies for FeNO testing, facilitating its wider adoption in clinical practices across the country.
  • China: China has seen a rising adoption of FeNO testing due to the country's growing healthcare demands, particularly in urban areas. With an increasing prevalence of asthma and other respiratory diseases, Chinese healthcare providers are turning to FeNO testing as an effective diagnostic tool. The market is also benefiting from government efforts to enhance healthcare infrastructure and improve chronic disease management. Local manufacturers are developing cost-effective FeNO testing devices tailored to meet the needs of a broader population, which is helping to make the technology more accessible. Awareness campaigns and improvements in the overall healthcare system are driving market growth.
  • Germany: Germany's healthcare system is well-established, and the country has seen steady adoption of FeNO testing within clinical and research settings. In line with broader European healthcare trends, Germany has been focusing on improving early diagnosis and personalized treatment plans for asthma and other respiratory conditions. The country's regulatory environment supports the use of FeNO testing, with strong integration into clinical guidelines for asthma management. Moreover, German medical device manufacturers are advancing FeNO testing technologies, incorporating features such as wireless connectivity for data sharing and integration with electronic health records, enhancing overall patient care.
  • India: In India, FeNO testing is still emerging but gaining momentum, particularly in larger cities with better healthcare infrastructure. The increasing awareness of asthma, along with the rising prevalence of air pollution-related respiratory conditions, has highlighted the need for advanced diagnostic tools. However, the adoption of FeNO testing is hampered by cost-related concerns, though the growing availability of affordable, portable devices is expected to increase adoption. Local healthcare initiatives are also working to improve access to non-invasive diagnostic tools for asthma and COPD, which could drive further growth in the FeNO testing market in the coming years.
  • Japan: Japan has been a leader in adopting advanced diagnostic tools, and FeNO testing is becoming more integrated into the management of respiratory conditions, especially in asthma. The country is focusing on advancing precision medicine and improving the monitoring of chronic diseases through non-invasive technologies. FeNO testing is included in national guidelines for asthma management, increasing its usage among healthcare professionals. The Japanese market is seeing innovations in FeNO measurement devices, including improved sensitivity and the development of home-use testing kits, offering more convenient and patient-friendly options for asthma monitoring and management.

Features of the Global FeNO Testing Market

  • Market Size Estimates: FeNO testing market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: FeNO testing market size by type, application, and region in terms of value ($B).
  • Regional Analysis: FeNO testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the FeNO testing market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the FeNO testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the FeNO testing market by type (nitric oxide standalone monitor, nitric oxide handheld monitor, and others), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global FeNO Testing Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Nitric Oxide Standalone Monitor: Trends and Forecast (2019-2031)
  • 4.4 Nitric Oxide Handheld Monitor: Trends and Forecast (2019-2031)
  • 4.5 Others: Trends and Forecast (2019-2031)

5. Global FeNO Testing Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospital: Trends and Forecast (2019-2031)
  • 5.4 Clinic: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global FeNO Testing Market by Region

7. North American FeNO Testing Market

  • 7.1 Overview
  • 7.4 United States FeNO Testing Market
  • 7.5 Mexican FeNO Testing Market
  • 7.6 Canadian FeNO Testing Market

8. European FeNO Testing Market

  • 8.1 Overview
  • 8.4 German FeNO Testing Market
  • 8.5 French FeNO Testing Market
  • 8.6 Spanish FeNO Testing Market
  • 8.7 Italian FeNO Testing Market
  • 8.8 United Kingdom FeNO Testing Market

9. APAC FeNO Testing Market

  • 9.1 Overview
  • 9.4 Japanese FeNO Testing Market
  • 9.5 Indian FeNO Testing Market
  • 9.6 Chinese FeNO Testing Market
  • 9.7 South Korean FeNO Testing Market
  • 9.8 Indonesian FeNO Testing Market

10. ROW FeNO Testing Market

  • 10.1 Overview
  • 10.4 Middle Eastern FeNO Testing Market
  • 10.5 South American FeNO Testing Market
  • 10.6 African FeNO Testing Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global FeNO Testing Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Guangzhou Kingmed Diagnostics
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Hangzhou Clongene Biotech
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Shanghai Fosun Long March Medical Science
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Nanjing Norman Biological Technology
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Beijing Eastwest Harmony Medical Devices
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Guangzhou Yercon Diagnostic
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Aeonmed
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global FeNO Testing Market
  • Figure 2.1: Usage of FeNO Testing Market
  • Figure 2.2: Classification of the Global FeNO Testing Market
  • Figure 2.3: Supply Chain of the Global FeNO Testing Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the FeNO Testing Market
  • Figure 4.1: Global FeNO Testing Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global FeNO Testing Market ($B) by Type
  • Figure 4.3: Forecast for the Global FeNO Testing Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Nitric Oxide Standalone Monitor in the Global FeNO Testing Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Nitric Oxide Handheld Monitor in the Global FeNO Testing Market (2019-2031)
  • Figure 4.6: Trends and Forecast for Others in the Global FeNO Testing Market (2019-2031)
  • Figure 5.1: Global FeNO Testing Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global FeNO Testing Market ($B) by Application
  • Figure 5.3: Forecast for the Global FeNO Testing Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospital in the Global FeNO Testing Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Clinic in the Global FeNO Testing Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global FeNO Testing Market (2019-2031)
  • Figure 6.1: Trends of the Global FeNO Testing Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global FeNO Testing Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American FeNO Testing Market (2019-2031)
  • Figure 7.2: North American FeNO Testing Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American FeNO Testing Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American FeNO Testing Market ($B) by Type (2025-2031)
  • Figure 7.5: North American FeNO Testing Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American FeNO Testing Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American FeNO Testing Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States FeNO Testing Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican FeNO Testing Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian FeNO Testing Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European FeNO Testing Market (2019-2031)
  • Figure 8.2: European FeNO Testing Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European FeNO Testing Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European FeNO Testing Market ($B) by Type (2025-2031)
  • Figure 8.5: European FeNO Testing Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European FeNO Testing Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European FeNO Testing Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German FeNO Testing Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French FeNO Testing Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish FeNO Testing Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian FeNO Testing Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom FeNO Testing Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC FeNO Testing Market (2019-2031)
  • Figure 9.2: APAC FeNO Testing Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC FeNO Testing Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC FeNO Testing Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC FeNO Testing Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC FeNO Testing Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC FeNO Testing Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese FeNO Testing Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian FeNO Testing Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese FeNO Testing Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean FeNO Testing Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian FeNO Testing Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW FeNO Testing Market (2019-2031)
  • Figure 10.2: ROW FeNO Testing Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW FeNO Testing Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW FeNO Testing Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW FeNO Testing Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW FeNO Testing Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW FeNO Testing Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern FeNO Testing Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American FeNO Testing Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African FeNO Testing Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global FeNO Testing Market
  • Figure 11.2: Market Share (%) of Top Players in the Global FeNO Testing Market (2024)
  • Figure 12.1: Growth Opportunities for the Global FeNO Testing Market by Type
  • Figure 12.2: Growth Opportunities for the Global FeNO Testing Market by Application
  • Figure 12.3: Growth Opportunities for the Global FeNO Testing Market by Region
  • Figure 12.4: Emerging Trends in the Global FeNO Testing Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the FeNO Testing Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the FeNO Testing Market by Region
  • Table 1.3: Global FeNO Testing Market Parameters and Attributes
  • Table 3.1: Trends of the Global FeNO Testing Market (2019-2024)
  • Table 3.2: Forecast for the Global FeNO Testing Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global FeNO Testing Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global FeNO Testing Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global FeNO Testing Market (2025-2031)
  • Table 4.4: Trends of Nitric Oxide Standalone Monitor in the Global FeNO Testing Market (2019-2024)
  • Table 4.5: Forecast for Nitric Oxide Standalone Monitor in the Global FeNO Testing Market (2025-2031)
  • Table 4.6: Trends of Nitric Oxide Handheld Monitor in the Global FeNO Testing Market (2019-2024)
  • Table 4.7: Forecast for Nitric Oxide Handheld Monitor in the Global FeNO Testing Market (2025-2031)
  • Table 4.8: Trends of Others in the Global FeNO Testing Market (2019-2024)
  • Table 4.9: Forecast for Others in the Global FeNO Testing Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global FeNO Testing Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global FeNO Testing Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global FeNO Testing Market (2025-2031)
  • Table 5.4: Trends of Hospital in the Global FeNO Testing Market (2019-2024)
  • Table 5.5: Forecast for Hospital in the Global FeNO Testing Market (2025-2031)
  • Table 5.6: Trends of Clinic in the Global FeNO Testing Market (2019-2024)
  • Table 5.7: Forecast for Clinic in the Global FeNO Testing Market (2025-2031)
  • Table 5.8: Trends of Others in the Global FeNO Testing Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global FeNO Testing Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global FeNO Testing Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global FeNO Testing Market (2025-2031)
  • Table 7.1: Trends of the North American FeNO Testing Market (2019-2024)
  • Table 7.2: Forecast for the North American FeNO Testing Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American FeNO Testing Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American FeNO Testing Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American FeNO Testing Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American FeNO Testing Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States FeNO Testing Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican FeNO Testing Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian FeNO Testing Market (2019-2031)
  • Table 8.1: Trends of the European FeNO Testing Market (2019-2024)
  • Table 8.2: Forecast for the European FeNO Testing Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European FeNO Testing Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European FeNO Testing Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European FeNO Testing Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European FeNO Testing Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German FeNO Testing Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French FeNO Testing Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish FeNO Testing Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian FeNO Testing Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom FeNO Testing Market (2019-2031)
  • Table 9.1: Trends of the APAC FeNO Testing Market (2019-2024)
  • Table 9.2: Forecast for the APAC FeNO Testing Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC FeNO Testing Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC FeNO Testing Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC FeNO Testing Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC FeNO Testing Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese FeNO Testing Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian FeNO Testing Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese FeNO Testing Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean FeNO Testing Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian FeNO Testing Market (2019-2031)
  • Table 10.1: Trends of the ROW FeNO Testing Market (2019-2024)
  • Table 10.2: Forecast for the ROW FeNO Testing Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW FeNO Testing Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW FeNO Testing Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW FeNO Testing Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW FeNO Testing Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern FeNO Testing Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American FeNO Testing Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African FeNO Testing Market (2019-2031)
  • Table 11.1: Product Mapping of FeNO Testing Suppliers Based on Segments
  • Table 11.2: Operational Integration of FeNO Testing Manufacturers
  • Table 11.3: Rankings of Suppliers Based on FeNO Testing Revenue
  • Table 12.1: New Product Launches by Major FeNO Testing Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global FeNO Testing Market